Panelists discuss how payer access challenges can determine whether patients receive therapy at all, with strategies including hospitalization for first cycles, advance prescription preparation, and ...
It take a lot of hard work behind the scenes to create seamless patient experiences. In this episode of HL Shorts, Seth Katz, vice president of revenue cycle and HIM at University City, discusses the ...
Health systems are increasingly shifting care online, but many are not assessing whether patients can use digital tools. Patients are commonly expected to schedule appointments, refill prescriptions, ...
Despite systemic challenges, oncology practices use value-based care, community partnerships, and clinical trials to improve patient access and outcomes, says Brian Mulherin, MD. What operational or ...
Strengthening patient-centered transitions of care enhances communication and reduces rehospitalization for chronic illness patients across settings.
Fewer patients are experiencing obstacles to accessing healthcare, according to a new survey, although persistent systemic issues limit improvements. How will this affect the revenue cycle? There is ...
Payers and providers are eager to elevate the patient journey, but for many patients, it still begins with friction. Extended wait times, complex intake processes, and unclear billing can derail the ...
Language barriers contribute substantially to inequities in U.S. surgical care. Spanish-speaking patients are especially ...
For many Minnesotans, the local independent pharmacy is the most accessible and consistent point of care in the health system. Whether it's a senior managing multiple chronic conditions, a parent ...
Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today announced that Imprivata Patient Access is now ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Cobenfy (xanomeline/trospium chloride; formerly KarXT) was ...